Alzheimer's Disease (AD) is the main contributor to the syndrome dementia, one for which no cure has yet been developed. One of the key issues with developing a cure is the presence of the blood... Show moreAlzheimer's Disease (AD) is the main contributor to the syndrome dementia, one for which no cure has yet been developed. One of the key issues with developing a cure is the presence of the blood-brain barrier (BBB), a restrictive network involving the cerebral vasculature which prevents passage of therapeutics into the brain. Currently many if not all of the clinically most advanced therapeutic avenues involve the use of antibodies to target the production, oligomerization and aggregation of the peptide Amyloid beta. In this thesis, an antibody variant derived from camelids, such as llamas, is examined. The llama antibody is devoid of the light chain, and therefore significantly smaller and easier to manipulate than conventional antibodies. Various strategies have been explored, including the use ofdirect intrathecal injections, liposomes and adeno associated virusses to allow the llama antibody fragment to enter and remain in the brain of mouse models of AD. Various imaging modalities are used to determine the success of BBB passage, including micro-SPECT, intravital multiphoton microscopy, in vivo whole body fluorescence imaging and ex vivo IHC and IF. The thesis supplies a foundation for delivery of llama antibody fragments into the brain. Show less
Dorresteijn, B.; Rotman, M.; Faber, D.; Schravesande, R.; Suidgeest, E.; Weerd, L. van der; ... ; Khattabi, M. el 2015